ACURA PHARMACEUTICALS, INC: auditor change — Acura Pharmaceuticals appoints new auditor after Cherry Bekaert termination

ACURA PHARMACEUTICALS, INC

Cherry Bekaert LLP terminated as auditor on Jan 30, 2024; no disagreements or reportable events cited.
Berkowitz, Pollack Brant Advisors + CPAs appointed on Jan 31, 2024 for FY2022 and FY2023 audits.
Prior auditor PKF Mueller was acquired by Cherry Bekaert in Oct 2023, leading to the withdrawal.
Company conducted a competitive process to select the new independent registered public accounting firm.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ACURA PHARMACEUTICALS, INC engaged Berkowitz, Pollack Brant Advisors + CPAs, LLP as its auditor.

Action: engagement
Auditor: Berkowitz, Pollack Brant Advisors + CPAs, LLP

Exact text from the filing

On January 31, 2024, the Audit Committee approved the appointment of Berkowitz, Pollack Brant Advisors + CPAs, LLP as the Company’s new independent registered public accounting firm

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001104659-24-009817

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.